Presentations & Publications

Corporate Presentation

Download Presentation

Download Poster

Download Poster

Download Poster

Interview with OKYO CEO Robert Dempsey and Steve Darling from Proactive Discussing FDA Type C Meeting (Jan 2026)

Interview with CEO Gary Jacob and Steve Darling from Proactive to share the top-line results from the recently completed Phase 2 trial . (July 2025)

Interview with CEO Robert Dempsey on OKYO Pharma Strengthening Scientific Advisory Board With Marta Sacchetti Appointment (May 2026)

Interview with OKYO Pharma CEO, Gary Jacob following the announcement of the early closure of NCP Trial to gain access to efficacy data. (April 2025)

OKYO CEO Gary Jacob talks to RedChip about the recent initiation of the Phase 2 trial for Neuropathic Corneal Pain (NCP) (Nov 2024)